Option chain shows key data for NervGen Pharma's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for NervGen Pharma.

NervGen Pharma (OTC:NGENF) Stock, Option Chain

NervGen Pharma Corp principal business activity is the discovery, development, and commercialization of pharmaceutical treatments that enable the nervous system to repair itself following damage, whether due to injury or disease. The company's initial target indication is spinal cord injury. The company's pipeline products include NVG-291, and NVG-300.

Has The Controversy Around Falsified Alzheimer’s Research Impacted The Path To Finding The Cure?

Biotech

Penny Stocks

General

BIIB

NGENF

ESALY

Finding the cure to Alzheimer’s has confounded researchers for decades.

As a disease, Alzheimer’s is highly complex and has a wide range of symptoms, including sleeplessness, wandering, agitation, anxiety, aggression, restlessness and depression. 

Has The Controversy Around Falsified Alzheimer&#39;s Research Impacted The Path To Finding The Cure?

NERVGEN PHARMA CORP by NervGen Pharma Corp.

NervGen Pharma Corp

News

Press Releases

Non-Opioid Revolution: Beacons of Hope in Opioid Crisis and a $50 Million Spin-Off

NervGen Pharma Announces Results of Annual General Meeting of Shareholders

NervGen Pharma Grants Stock Options

Life Sciences Investor Forum Agenda Announced for March 13th

Life Science Virtual Investor Forum: Presentations Now Available for Online Viewing

Comments

NervGen Pharma

NervGen Pharma (NGENF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga